Tags

Type your tag names separated by a space and hit enter

Anti-proliferating effect of iptakalim, a novel KATP channel opener, in cultured rabbit pulmonary arterial smooth muscle cells.
Eur J Pharmacol. 2005 Mar 28; 511(2-3):81-7.EJ

Abstract

ATP-sensitive potassium (K(ATP)) channels of pulmonary arterial smooth muscle cells (SMCs) have been implicated in pulmonary hypertension. Iptakalim, designed and synthesized by ourselves, is a newly selective K(ATP) channel opener. Here, we explored the effects of iptakalim on the rise of cytoplasmic free Ca(2+) concentration ([Ca(2+)](cyt)) induced by endothelin-1 (ET-1) and on the proliferation of cultured rabbit pulmonary arterial SMCs. The results showed that iptakalim inhibited the [Ca(2+)](cyt) increase. The enhanced [(3)H]thymidine incorporation was inhibited and the transition of cells from static phase (G(0)/G(1)) to DNA synthesis (S) and mitotic phase (G(2)/M) was held back by iptakalim in a concentration-dependent manner. Glyburide abolished the inhibitory effect of iptakalim. In conclusion, we have shown that iptakalim had an inhibitory effect on [Ca(2+)](cyt) increase and the proliferation of pulmonary arterial SMCs induced by endothelin-1 through activation of K(ATP) channels. These findings suggest that iptakalim might be a promising candidate for the treatment of pulmonary arterial remodeling in pulmonary hypertension.

Authors+Show Affiliations

Department of Pharmacology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, Jiangsu 210029, China.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15792775

Citation

Xie, Weiping, et al. "Anti-proliferating Effect of Iptakalim, a Novel KATP Channel Opener, in Cultured Rabbit Pulmonary Arterial Smooth Muscle Cells." European Journal of Pharmacology, vol. 511, no. 2-3, 2005, pp. 81-7.
Xie W, Wang H, Ding J, et al. Anti-proliferating effect of iptakalim, a novel KATP channel opener, in cultured rabbit pulmonary arterial smooth muscle cells. Eur J Pharmacol. 2005;511(2-3):81-7.
Xie, W., Wang, H., Ding, J., Wang, H., & Hu, G. (2005). Anti-proliferating effect of iptakalim, a novel KATP channel opener, in cultured rabbit pulmonary arterial smooth muscle cells. European Journal of Pharmacology, 511(2-3), 81-7.
Xie W, et al. Anti-proliferating Effect of Iptakalim, a Novel KATP Channel Opener, in Cultured Rabbit Pulmonary Arterial Smooth Muscle Cells. Eur J Pharmacol. 2005 Mar 28;511(2-3):81-7. PubMed PMID: 15792775.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Anti-proliferating effect of iptakalim, a novel KATP channel opener, in cultured rabbit pulmonary arterial smooth muscle cells. AU - Xie,Weiping, AU - Wang,Hong, AU - Ding,Jianhua, AU - Wang,Hai, AU - Hu,Gang, PY - 2004/12/07/received PY - 2005/01/24/revised PY - 2005/01/28/accepted PY - 2005/3/29/pubmed PY - 2005/7/27/medline PY - 2005/3/29/entrez SP - 81 EP - 7 JF - European journal of pharmacology JO - Eur J Pharmacol VL - 511 IS - 2-3 N2 - ATP-sensitive potassium (K(ATP)) channels of pulmonary arterial smooth muscle cells (SMCs) have been implicated in pulmonary hypertension. Iptakalim, designed and synthesized by ourselves, is a newly selective K(ATP) channel opener. Here, we explored the effects of iptakalim on the rise of cytoplasmic free Ca(2+) concentration ([Ca(2+)](cyt)) induced by endothelin-1 (ET-1) and on the proliferation of cultured rabbit pulmonary arterial SMCs. The results showed that iptakalim inhibited the [Ca(2+)](cyt) increase. The enhanced [(3)H]thymidine incorporation was inhibited and the transition of cells from static phase (G(0)/G(1)) to DNA synthesis (S) and mitotic phase (G(2)/M) was held back by iptakalim in a concentration-dependent manner. Glyburide abolished the inhibitory effect of iptakalim. In conclusion, we have shown that iptakalim had an inhibitory effect on [Ca(2+)](cyt) increase and the proliferation of pulmonary arterial SMCs induced by endothelin-1 through activation of K(ATP) channels. These findings suggest that iptakalim might be a promising candidate for the treatment of pulmonary arterial remodeling in pulmonary hypertension. SN - 0014-2999 UR - https://www.unboundmedicine.com/medline/citation/15792775/Anti_proliferating_effect_of_iptakalim_a_novel_KATP_channel_opener_in_cultured_rabbit_pulmonary_arterial_smooth_muscle_cells_ DB - PRIME DP - Unbound Medicine ER -